MedPath

Determining the role of Liver enzymes and Platelet counts in predicting the severity of Dengue fever

Not Applicable
Conditions
Health Condition 1: A90-A99- Arthropod-borne viral fevers and viral hemorrhagic fevers
Registration Number
CTRI/2024/07/071075
Lead Sponsor
Department of General Medicine Kasturba Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients more than 18 years of age diagnosed with dengue by either NS1 antigen assay or by Anti-Dengue IgM assay

Exclusion Criteria

Patients with preexisting liver disease

Patients testing positive for HIV HBV HCV on routine serological testing

Patients with other causes of thrombocytopenia including ITP

Patients with abnormalities in hematological cell lines

Patients with secondary bacterial infections

Patients not willing to provide consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
At the end of the study APRI values in different groups of dengue illness will be studied and compared. APRI values of severe dengue, dengue with warning signs and dengue without warning signs <br/ ><br>Timepoint: Cross Sectional Study
Secondary Outcome Measures
NameTimeMethod
APRI values in dengue survivors and dengue related deaths <br/ ><br>APRI values in different types of complications of dengue will be compared <br/ ><br>Degree of association between severity and APRI would be estimated.Timepoint: Cross Sectional Study
© Copyright 2025. All Rights Reserved by MedPath